EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors

Chun-Chia Cheng, Hong-Zen Yeh, Zong-Lin Sie, Chih-Liang Wang, Cheng-Liang Peng, Ai-Sheng Ho, Chun-I Wang, Chun-Chao Chang

Cancer Immunology, Immunotherapy · 07.02.2026 · 75 (3)

DOI: 10.1007/s00262-026-04300-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 07.02.2026. Verfasst von Chun-Chia Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Radiation Medicine, Chang Gung University, Taoyuan, 333, Taiwan. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Macrophages, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT), widely employed in clinical practice to suppress tumor progression, exhibits an abscopal effect that enhances immunogenic activity to potentially benefit immunotherapeutic efficacy. However, the tumor types most likely to exhibit such effects remain unclear. Since TP53-wild type tumors are sensitive to RT, we hypothesized and aimed to investigate whether these tumors are prone to RT-induced abscopal effects. Bioinformatic analyses with RNAseq were conducted to identify the differentially expressed genes. Next, quantitative polymerase chain reaction with flow cytometry was used to assess the potential mechanism. In liver hepatocellular carcinoma (LIHC), a cancer type with a 27% TP53 mutation (therefore 73% TP53-wild type), we noticed that p53 expression positively correlated with the 15 selective immunotherapy-associated genes. We consequently validated that the IFNγ-up-regulated genes in TP53-wild type A549 cells were correlated with better immunotherapeutic outcomes. In contrast, RT induced a distinct set of genes enriched in p53 signaling pathways to correlate with better survival in LIHC patients, but not with immunotherapeutic response. Even so, we found that RT specifically induced apoptosis in TP53-wild type HCT116 cells compared to TP53null HCT116 cells to significantly promote immune cell activation in vitro. We consequently demonstrated the major factors, including IFNα and IFNγ expression, induced by RT in TP53-wild type tumors potentially enhance M1 macrophage polarization, whereas these effects were absent in TP53null models. In conclusion, our findings demonstrate that RT specifically suppressed TP53-wild type tumors, leading to IFNs expression. The RT-mediated immunogenic activation was potentially derived from the RT-induced IFNs, which were speculated to contribute to M1 macrophage polarization and immunogenic activity. These results suggest TP53-wild type tumors may be ideal candidates for combining RT and immunotherapy in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53MacrophagesLiver NeoplasmsCarcinoma, HepatocellularInterferonsHumansAnimalsMiceImmunotherapyMacrophage ActivationFemale

Stichwörter der Autor:innen

IFNsImmunotherapyM1 macrophageRadiotherapyTP53

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanInterferons

Autor:innen und Institutionen

  • Research Center of Radiation Medicine, Chang Gung University, Taoyuan, 333, Taiwan.
  • Division of Pulmonary Oncology and Interventional Bronchoscopy, Department of Thoracic Medicine, Chang Gung Memorial Hospital, Linkou, Taoyuan, 333, Taiwan.
  • Division of Gastroenterology and Hepatology, Tungs' Taichung Metro Harbor Hospital, Taichung, 406, Taiwan.
  • Department of Isotope Application Research, National Atomic Research Institute, Taoyuan, 325, Taiwan.
  • Division of Gastroenterology, Cheng Hsin General Hospital, Taipei, 112, Taiwan.
  • Department of Biochemistry, School of Medicine, China Medical University, Taichung, 400, Taiwan. ciwang@mail.cmu.edu.tw.

Förderung

  • the National Science and Technology Council, Taiwan

Zitieren

APA

Cheng, C. C., Yeh, H. Z., Sie, Z. L., Wang, C. L., Peng, C. L., Ho, A. S., Wang, C. I., & Chang, C. C. (2026). Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors. Cancer Immunology, Immunotherapy, 75(3). https://doi.org/10.1007/s00262-026-04300-7

Vancouver

Cheng CC, Yeh HZ, Sie ZL, Wang CL, Peng CL, Ho AS, et al. Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors. Cancer Immunology, Immunotherapy. 2026;75(3). doi:10.1007/s00262-026-04300-7

BibTeX
@article{Cheng2026,
  author = {Cheng, Chun-Chia and Yeh, Hong-Zen and Sie, Zong-Lin and Wang, Chih-Liang and Peng, Cheng-Liang and Ho, Ai-Sheng and Wang, Chun-I and Chang, Chun-Chao},
  title = {Radiotherapy enhances M1 macrophage immunogenic activity through IFNs induction and stimulation in TP53-wild type tumors},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {3},
  doi = {10.1007/s00262-026-04300-7}
}
Kostenlos starten →